IRX · ASX

InhaleRx Limited (ASX:IRX)

AU$0.026

 -0.008 (-23.529%)
ASX:Live
23/10/2024 03:12:33 PM
Volume Spike HALO Ords GROWTH AUS Big Candle All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

IRX Overview

IRX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

IRX Price Chart

Key Stats

Market Cap

AU$6.07M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.0

Trade Value (12mth)

N/A

1 week

36.36%

1 month

-9.09%

YTD

7.14%

1 year

-28.57%

All time high

N/A

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

N/A

Short Sell (% of issue)

N/A

IRX Announcements

Latest Announcements

Date Announcements

18 October 24

$38.5m Funding to Fully Fund Clinical Development Plans

×

$38.5m Funding to Fully Fund Clinical Development Plans

18 October 24

Proposed issue of securities - IRX

×

Proposed issue of securities - IRX

03 October 24

Application for quotation of securities - IRX

×

Application for quotation of securities - IRX

02 October 24

Issue of Shares to CEO in Lieu of Accrued Salary

×

Issue of Shares to CEO in Lieu of Accrued Salary

02 October 24

Proposed issue of securities - IRX

×

Proposed issue of securities - IRX

30 August 24

Half Yearly Report and Accounts

×

Half Yearly Report and Accounts

31 July 24

Jun24 Appendix 4C Cash Flow Report

×

Jun24 Appendix 4C Cash Flow Report

31 July 24

Jun24 Quarterly Activities Report

×

Jun24 Quarterly Activities Report

25 July 24

Live Investor Webinar

×

Live Investor Webinar

05 July 24

IRX616a IND Application Outcome

×

IRX616a IND Application Outcome

03 July 24

Final Clinical Study Report Received, Phase 1 IRX-211

×

Final Clinical Study Report Received, Phase 1 IRX-211

06 June 24

Change of Director's Interest Notice - Sean Williams

×

Change of Director's Interest Notice - Sean Williams

03 June 24

Notification regarding unquoted securities - IRX

×

Notification regarding unquoted securities - IRX

31 May 24

AGM Results

×

AGM Results

30 May 24

Significant Milestone - IND submitted to the FDA for IRX616a

×

Significant Milestone - IND submitted to the FDA for IRX616a

30 May 24

2024 AGM Slides

×

2024 AGM Slides

30 April 24

Notice of Annual General Meeting

×

Notice of Annual General Meeting

30 April 24

AGM Sample Proxy Form

×

AGM Sample Proxy Form

30 April 24

AGM Access Letter

×

AGM Access Letter

30 April 24

Mar24 Quarterly Activities Report

×

Mar24 Quarterly Activities Report

30 April 24

Mar24 Appendix 4C Cash Flow Report

×

Mar24 Appendix 4C Cash Flow Report

18 April 24

Change of Registered Office Address

×

Change of Registered Office Address

28 March 24

$500,000 Convertible Loan Facility

×

$500,000 Convertible Loan Facility

28 March 24

Annual Report to shareholders

×

Annual Report to shareholders

28 March 24

Corporate Governance Statement and Appendix 4G

×

Corporate Governance Statement and Appendix 4G

28 March 24

Appendix 4G

×

Appendix 4G

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

%

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IRX Shortsell

Frequently Asked Questions

The current share price of InhaleRx Limited (IRX:ASX) is AU$0.026.
The 52-week high share price for InhaleRx Limited (IRX:ASX) is AU$0.00.
The 52-week low share price for InhaleRx Limited (IRX:ASX)? is AU$0.00.
InhaleRx Limited (IRX:ASX) does not pay a dividend.
InhaleRx Limited (IRX:ASX) does not pay a dividend.
InhaleRx Limited (IRX:ASX) does not offer franking credits.
InhaleRx Limited (IRX:ASX) is classified in the Healthcare.